ResMed Inc. (LON:0KW4)
London
· Delayed Price · Currency is GBP · Price in USD 243.34
-2.34 (-0.95%)
At close: May 9, 2025
ResMed Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 4,685 | 4,223 | 3,578 | 3,197 | 2,957 | Upgrade
|
| Revenue Growth (YoY) | 10.95% | 18.02% | 11.93% | 8.11% | 13.44% | Upgrade
|
| Cost of Revenue | 1,997 | 1,837 | 1,514 | 1,307 | 1,190 | Upgrade
|
| Gross Profit | 2,688 | 2,386 | 2,064 | 1,889 | 1,767 | Upgrade
|
| Selling, General & Admin | 917.14 | 874 | 737.51 | 670.39 | 676.69 | Upgrade
|
| Research & Development | 307.53 | 287.64 | 253.58 | 225.28 | 201.95 | Upgrade
|
| Operating Expenses | 1,304 | 1,234 | 1,062 | 971.88 | 958.33 | Upgrade
|
| Operating Income | 1,384 | 1,152 | 1,002 | 917.55 | 809.06 | Upgrade
|
| Interest Expense | -49.72 | -51.13 | -22.31 | -23.63 | -39.36 | Upgrade
|
| Earnings From Equity Investments | -1.85 | -7.27 | -8.49 | -11.21 | -25.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.14 | -0.45 | 2.81 | -0.75 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.66 | -1.51 | 0.39 | 1.05 | 2.36 | Upgrade
|
| EBT Excluding Unusual Items | 1,333 | 1,092 | 974.55 | 883.02 | 747.01 | Upgrade
|
| Merger & Restructuring Charges | -64.23 | -20.13 | -1.86 | -13.87 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.05 | 9.92 | -12.2 | 14.52 | -14.52 | Upgrade
|
| Legal Settlements | - | - | - | - | 0.6 | Upgrade
|
| Pretax Income | 1,265 | 1,102 | 960.48 | 883.66 | 733.09 | Upgrade
|
| Income Tax Expense | 243.85 | 204.11 | 181.05 | 409.16 | 111.41 | Upgrade
|
| Net Income | 1,021 | 897.56 | 779.44 | 474.51 | 621.67 | Upgrade
|
| Net Income to Common | 1,021 | 897.56 | 779.44 | 474.51 | 621.67 | Upgrade
|
| Net Income Growth | 13.75% | 15.15% | 64.26% | -23.67% | 53.65% | Upgrade
|
| Shares Outstanding (Basic) | 147 | 147 | 146 | 145 | 144 | Upgrade
|
| Shares Outstanding (Diluted) | 148 | 147 | 147 | 146 | 146 | Upgrade
|
| Shares Change (YoY) | 0.06% | 0.28% | 0.40% | 0.55% | 0.81% | Upgrade
|
| EPS (Basic) | 6.94 | 6.12 | 5.34 | 3.27 | 4.31 | Upgrade
|
| EPS (Diluted) | 6.92 | 6.09 | 5.30 | 3.24 | 4.27 | Upgrade
|
| EPS Growth | 13.63% | 14.91% | 63.58% | -24.12% | 52.50% | Upgrade
|
| Free Cash Flow | 1,302 | 573.63 | 216.31 | 634.01 | 706.93 | Upgrade
|
| Free Cash Flow Per Share | 8.82 | 3.89 | 1.47 | 4.33 | 4.85 | Upgrade
|
| Dividend Per Share | 1.920 | 1.760 | 1.680 | 1.590 | 1.560 | Upgrade
|
| Dividend Growth | 9.09% | 4.76% | 5.66% | 1.92% | 4.00% | Upgrade
|
| Gross Margin | 57.38% | 56.50% | 57.68% | 59.10% | 59.77% | Upgrade
|
| Operating Margin | 29.54% | 27.28% | 28.01% | 28.70% | 27.36% | Upgrade
|
| Profit Margin | 21.79% | 21.25% | 21.78% | 14.84% | 21.02% | Upgrade
|
| Free Cash Flow Margin | 27.79% | 13.58% | 6.04% | 19.83% | 23.91% | Upgrade
|
| EBITDA | 1,534 | 1,292 | 1,126 | 1,029 | 922.89 | Upgrade
|
| EBITDA Margin | 32.73% | 30.60% | 31.47% | 32.19% | 31.21% | Upgrade
|
| D&A For EBITDA | 149.42 | 140.1 | 124.06 | 111.43 | 113.83 | Upgrade
|
| EBIT | 1,384 | 1,152 | 1,002 | 917.55 | 809.06 | Upgrade
|
| EBIT Margin | 29.54% | 27.28% | 28.01% | 28.70% | 27.36% | Upgrade
|
| Effective Tax Rate | 19.28% | 18.53% | 18.85% | 46.30% | 15.20% | Upgrade
|
| Revenue as Reported | 4,685 | 4,223 | 3,578 | 3,197 | 2,957 | Upgrade
|
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.